Non-coding RNAs and ferroptosis: potential implications for cancer therapy

Area of Science:

• Biochemistry
• Cell Biology
• Oncology

Background:

• Ferroptosis is a distinct form of regulated cell death involving iron, reactive oxygen species, and lipid peroxidation.
• This cell death pathway is often suppressed in cancer, contributing to tumor survival and progression.
• Non-coding RNAs (ncRNAs) are key regulators of cellular processes, including cancer development and ferroptosis.

Purpose of the Study:

• To review the role of non-coding RNAs (ncRNAs) in regulating ferroptosis within cancer.
• To elucidate the molecular mechanisms by which ncRNAs control ferroptosis in cancer.
• To highlight the therapeutic potential of ncRNA-based strategies for modulating ferroptosis in cancer treatment.

Main Methods:

• Literature review of studies on ferroptosis, cancer, and non-coding RNAs.
• Analysis of molecular mechanisms linking ncRNAs to ferroptosis regulation.
• Synthesis of findings regarding therapeutic applications of ncRNA-based ferroptosis modulation.

Main Results:

• Ferroptosis is frequently suppressed in cancer cells, conferring resistance to conventional therapies.
• ncRNAs play critical roles in controlling ferroptosis pathways in cancer.
• Targeting ncRNAs offers a promising avenue for inducing ferroptosis and treating drug-resistant cancers.

Conclusions:

• ncRNAs are integral regulators of ferroptosis in the context of cancer.
• Understanding these ncRNA-mediated mechanisms is crucial for developing novel cancer therapies.
• ncRNA-based therapeutics hold significant potential for exploiting ferroptosis in cancer treatment.